IRIS UniCatt

Rapaccini, Gian Ludovico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.217
EU - Europa 7.534
AS - Asia 6.345
SA - Sud America 1.384
AF - Africa 184
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 16
Totale 23.702
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.989
SG - Singapore 3.020
DE - Germania 2.720
CN - Cina 1.786
SE - Svezia 1.377
BR - Brasile 1.149
IT - Italia 669
UA - Ucraina 591
FR - Francia 445
IE - Irlanda 426
GB - Regno Unito 389
VN - Vietnam 277
FI - Finlandia 268
ID - Indonesia 253
IN - India 234
RU - Federazione Russa 170
TR - Turchia 158
PL - Polonia 116
CA - Canada 103
JP - Giappone 97
AR - Argentina 94
BD - Bangladesh 82
HK - Hong Kong 71
IQ - Iraq 60
BE - Belgio 58
KR - Corea 58
MX - Messico 57
AT - Austria 54
ZA - Sudafrica 53
NL - Olanda 52
ES - Italia 43
EC - Ecuador 38
CI - Costa d'Avorio 37
SA - Arabia Saudita 34
CZ - Repubblica Ceca 27
MA - Marocco 27
LT - Lituania 25
PK - Pakistan 25
VE - Venezuela 24
CH - Svizzera 21
IR - Iran 21
AE - Emirati Arabi Uniti 20
UZ - Uzbekistan 20
CO - Colombia 19
CL - Cile 17
EU - Europa 16
KE - Kenya 16
RO - Romania 15
BZ - Belize 14
EG - Egitto 14
AZ - Azerbaigian 13
PH - Filippine 13
JO - Giordania 12
PE - Perù 12
TW - Taiwan 12
UY - Uruguay 12
AU - Australia 11
BG - Bulgaria 11
IL - Israele 11
PT - Portogallo 10
PY - Paraguay 10
JM - Giamaica 9
PA - Panama 9
TT - Trinidad e Tobago 9
DZ - Algeria 8
GR - Grecia 8
HU - Ungheria 8
KG - Kirghizistan 8
KZ - Kazakistan 8
NP - Nepal 8
LB - Libano 6
CG - Congo 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
HN - Honduras 5
LK - Sri Lanka 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
AL - Albania 4
BO - Bolivia 4
BY - Bielorussia 4
CR - Costa Rica 4
ET - Etiopia 4
GE - Georgia 4
MD - Moldavia 4
NI - Nicaragua 4
OM - Oman 4
SC - Seychelles 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
GY - Guiana 3
MK - Macedonia 3
NO - Norvegia 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CY - Cipro 2
Totale 23.663
Salva come PNG Salva come JPEG
Città #
Singapore 1.426
Chandler 1.208
Ashburn 824
Dublin 424
Dallas 395
New York 362
Jacksonville 324
Beijing 322
San Mateo 250
Los Angeles 241
Jakarta 232
Nanjing 230
Hefei 228
Ann Arbor 163
Nürnberg 162
Boston 160
Wilmington 159
Houston 141
Dearborn 139
Munich 135
Princeton 125
Chicago 121
Helsinki 120
Milan 113
Moscow 112
Frankfurt am Main 107
Rome 106
Izmir 102
Ho Chi Minh City 100
Marseille 99
São Paulo 99
Cattolica 87
Woodbridge 79
Tokyo 76
Hanoi 73
Seattle 71
Nanchang 69
Buffalo 68
Kent 67
Hong Kong 66
The Dalles 64
Bremen 61
Redwood City 61
Redmond 60
Brussels 54
Fairfield 53
Seoul 53
Kraków 52
San Jose 49
Boardman 48
Shenyang 46
London 45
Warsaw 45
Santa Clara 42
Lawrence 41
Brooklyn 38
Hebei 38
Rio de Janeiro 38
Abidjan 37
Denver 37
Lancaster 36
Nuremberg 36
Tianjin 35
Belo Horizonte 34
Hyderabad 34
Mountain View 34
Phoenix 34
Stockholm 34
Norwalk 33
Zhengzhou 33
Chennai 32
Hangzhou 31
Guangzhou 30
Kunming 30
Pune 30
Toronto 30
University Park 29
Vienna 29
Montreal 28
Poplar 28
Atlanta 27
Baghdad 27
Changsha 27
Johannesburg 27
Shanghai 27
Turku 27
Augusta 26
San Francisco 25
Leawood 24
Bologna 23
Brasília 23
Jiaxing 23
Paris 22
Bexley 21
Manchester 21
North Bergen 21
Jinan 20
Las Vegas 20
Mexico City 20
Curitiba 19
Totale 11.457
Salva come PNG Salva come JPEG
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 442
Association between Klinefelter syndrome and focal nodular hyperplasia 314
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 251
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 228
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 224
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 219
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 217
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 213
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 199
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 192
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 191
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 190
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 186
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 186
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 180
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 177
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 176
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 176
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 174
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 173
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 173
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 168
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 167
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 164
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 162
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 161
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 158
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. 157
recurrent acute hepatitis associated with use of cetrizine 156
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 155
Liver transplantation in patients with alcoholic liver disease: A retrospective study 154
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 153
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 148
Potential use of liver function breath tests in the clinical practice. 147
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 147
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 146
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 143
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 141
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 139
Immunological role of IgG subclasses 139
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 139
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 137
Magnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy 136
Sarilumab use in severe SARS-CoV-2 pneumonia 136
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 132
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 132
Gastric wall thickness in normal and neoplastic subjects: a prospective study performed by abdominal ultrasound 131
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 131
DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy 130
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 128
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 128
Development and validation of predictive assessment of complicated diverticulitis score 128
Clinical suspicion of pancreatic neoplasm: does echo-guided fine-needle biopsy modify patient management? 127
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 125
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 125
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. 125
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 125
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 124
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 122
Doppler ultrasonographic evaluation of blood flow in the superior mesenteric artery in celiac patients and in healthy controls in fasting conditions and after saccharose ingestion 122
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 121
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 121
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 121
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 120
Lipohyperplasia of the ileocaecal valve as a cause of intestinal haemorrhage: an ultrasound Doppler study 119
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 119
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 118
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 118
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 117
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 117
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 117
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 116
[Liver transplantation] 115
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 115
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 115
Amantadine-induced livedo reticularis occurring during treatment of chronic hepatitis C 114
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 114
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. 113
Botulinum toxin-B ultrasound-guided injections for sialorrhea in amytrophic lateral sclerosis and Parkinson's disease 112
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 112
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 112
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 111
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 111
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 111
Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (< 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging 110
Liver transplantation in Italy: preliminary 10-year report. The Monotematica Aisf-Olt Study Group 109
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 109
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 108
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 108
Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy 107
Is coeliac disease a confounding factor in the diagnosis of NASH? 107
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 107
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study 106
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 105
Acute hepatitis associated with use of paroxetine 104
Ultrasound-Doppler diagnosis of Budd-Chiari syndrome 104
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience 104
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 103
Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation 103
Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk 103
Totale 14.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.350
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.350
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021708 0 0 0 0 0 41 115 28 168 58 260 38
2021/20221.642 110 118 39 140 102 54 34 221 66 107 283 368
2022/20233.728 476 436 268 501 295 431 226 314 444 97 163 77
2023/20242.063 114 554 64 135 80 353 113 88 26 125 160 251
2024/20254.010 108 107 377 117 344 166 107 220 579 354 848 683
2025/20266.275 1.520 289 919 1.303 1.829 415 0 0 0 0 0 0
Totale 23.972